167 related articles for article (PubMed ID: 18974148)
1. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer.
Aziz MH; Dreckschmidt NE; Verma AK
Cancer Res; 2008 Nov; 68(21):9024-32. PubMed ID: 18974148
[TBL] [Abstract][Full Text] [Related]
2. Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers.
Hafeez BB; Zhong W; Mustafa A; Fischer JW; Witkowsky O; Verma AK
Carcinogenesis; 2012 Dec; 33(12):2586-92. PubMed ID: 22976928
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.
Hafeez BB; Zhong W; Fischer JW; Mustafa A; Shi X; Meske L; Hong H; Cai W; Havighurst T; Kim K; Verma AK
Mol Oncol; 2013 Jun; 7(3):428-39. PubMed ID: 23273564
[TBL] [Abstract][Full Text] [Related]
4. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
5. Plumbagin Triggers ER Stress-Mediated Apoptosis in Prostate Cancer Cells via Induction of ROS.
Huang H; Xie H; Pan Y; Zheng K; Xia Y; Chen W
Cell Physiol Biochem; 2018; 45(1):267-280. PubMed ID: 29357323
[TBL] [Abstract][Full Text] [Related]
6. Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways.
Hafeez BB; Jamal MS; Fischer JW; Mustafa A; Verma AK
Int J Cancer; 2012 Nov; 131(9):2175-86. PubMed ID: 22322442
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK
Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
9. Proapoptotic and Growth-inhibitory Effects of Plumbagin on Human Gastric Cancer Cells Via Suppression of Signal Transducer and Activator of Transcription 3 and Protein Kinase B.
Li J; Li J; Cai G; Shen L; Lu F
Altern Ther Health Med; 2017 Sep; 23(5):42-48. PubMed ID: 28236621
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas.
Sand JM; Bin Hafeez B; Jamal MS; Witkowsky O; Siebers EM; Fischer J; Verma AK
Carcinogenesis; 2012 Jan; 33(1):184-90. PubMed ID: 22072620
[TBL] [Abstract][Full Text] [Related]
11. Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3.
Singh RP; Tyagi AK; Dhanalakshmi S; Agarwal R; Agarwal C
Int J Cancer; 2004 Feb; 108(5):733-40. PubMed ID: 14696100
[TBL] [Abstract][Full Text] [Related]
12. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.
Hu M; Peng S; He Y; Qin M; Cong X; Xing Y; Liu M; Yi Z
Oncotarget; 2015 Jun; 6(17):15348-61. PubMed ID: 25915156
[TBL] [Abstract][Full Text] [Related]
13. Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice.
Kikuchi E; Horiguchi Y; Nakashima J; Kuroda K; Oya M; Ohigashi T; Takahashi N; Shima Y; Umezawa K; Murai M
Cancer Res; 2003 Jan; 63(1):107-10. PubMed ID: 12517785
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells.
Wang T; Wu F; Jin Z; Zhai Z; Wang Y; Tu B; Yan W; Tang T
Food Chem Toxicol; 2014 Feb; 64():177-83. PubMed ID: 24296134
[TBL] [Abstract][Full Text] [Related]
15. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
Jing N; Li Y; Xiong W; Sha W; Jing L; Tweardy DJ
Cancer Res; 2004 Sep; 64(18):6603-9. PubMed ID: 15374974
[TBL] [Abstract][Full Text] [Related]
16. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
17. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915
[TBL] [Abstract][Full Text] [Related]
18. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
Jeon YJ; Jung SN; Yun J; Lee CW; Choi J; Lee YJ; Han DC; Kwon BM
Cancer Sci; 2015 Apr; 106(4):413-20. PubMed ID: 25611086
[TBL] [Abstract][Full Text] [Related]
19. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression.
Niu M; Cai W; Liu H; Chong Y; Hu W; Gao S; Shi Q; Zhou X; Liu X; Yu R
J Pharmacol Sci; 2015 Jul; 128(3):131-6. PubMed ID: 26154848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
